News
Imagine treating a genetic disease not by managing symptoms for life, but by correcting the underlying genetic error itself. Inventors at NIH are advancing that vision with a gene editing technology designed to deliver highly precise genetic corrections, opening new possibilities for therapies that
Register to attend a free NCI webinar. Attendees will learn about a new a djuvanted subunit mucosal Covid-19 vaccine. Study results show that this new vaccine prevents SARS-CoV-2 transmission and infection. Most SARS-CoV-2 vaccines focus on delivering immunization through an intramuscular injection
NIH is dedicated to researching rare diseases and collaborating with partners to bring products for rare diseases to market, not only during Rare Disease Week but throughout the year. As a result of such work, on November 22, 2022, the U.S. Food and Drug Administration approved Hemgenix®, the world
Are you interested in making an impact on the improvement of global health? Are you interested in working in a dynamic organization that values its employees and offers work-life flexibility? The National Institute of Allergy and Infectious Diseases (NIAID), one of the largest Institutes at the